Quercetin

Quercetin

SCHEMBL10323960

O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12.[KH]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.97
KMT2A Q03164 11/20 0.97
CYP1A2 P05177 8/20 0.97
CYP3A4 P08684 8/20 0.97
KDM4E B2RXH2 8/20 0.97
HSD17B10 Q99714 8/20 0.97
MAPT P10636 8/20 0.97
CYP2C9 P11712 7/20 0.97
RECQL P46063 7/20 0.97
CYP1A1 P04798 7/20 0.97
CYP1B1 Q16678 7/20 0.97
XDH P47989 7/20 0.97
FTO Q9C0B1 7/20 0.97
ALOX15 P16050 6/20 0.97
ABCB1 P08183 6/20 0.97
APP P05067 6/20 0.97
POLH Q9Y253 6/20 0.97
POLB P06746 5/20 0.97
TP53 P04637 5/20 0.97
IPMK Q8NFU5 5/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercetin SCHEMBL29353785 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL118425 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL29351036 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL19723 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL17629824 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL31507620 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL29723041 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL3786991 0.97 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL4815328 0.97 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL22103 0.97 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665467-A2 FLAVONOL COMPOSITIONS Ono, Mitsunori (US) 2013-11-27 EP claimed
WO-2012099930-A2 FLAVONOL COMPOSITIONS ONO MITSUNORI (US) 2012-07-26 WO claimed
US-20120183587-A1 FLAVONOL COMPOSITIONS LINES, THOMAS CHRISTIAN (CH) 2012-07-19 US claimed
CN-112716820-A Antibacterial skin-care lotion and preparation method thereof 广东好顺欧迪斯科技股份有限公司 2021-04-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120183587-A1 FLAVONOL COMPOSITIONS CYP2F1, F3, TEAD3 MEN1 2383/4885KMT2A 2991/4885CYP1A2 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.